Risk Factor Modification: Rationale for Management of Dyslipidemia

Publisher Website

1 February 1998

journal article
review article
Published by Elsevier in The American Journal of Medicine

Vol. 104 (2) , 6S-8S
https://doi.org/10.1016/s0002-9343(98)00039-4

Abstract

No abstract available

Keywords

This publication has 5 references indexed in Scilit:

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
New England Journal of Medicine, 1996
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goals
The American Journal of Medicine, 1996
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
New England Journal of Medicine, 1995
Lipid-lowering interventions in angiographic trials
The American Journal of Cardiology, 1995
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
New England Journal of Medicine, 1987